SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-142279
Filing Date
2020-05-14
Accepted
2020-05-14 08:20:32
Documents
3
Period of Report
2020-05-12
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d930766d8k.htm 8-K 21923
2 EX-99.1 d930766dex991.htm EX-99.1 9924
3 EX-99.2 d930766dex992.htm EX-99.2 20113
  Complete submission text file 0001193125-20-142279.txt   53198
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38906 | Film No.: 20875367
SIC: 2836 Biological Products, (No Diagnostic Substances)